Effect of treatment with benralizumab or mepolizumab on the serum proteome in eosinophilic granulomatosis with polyangiitis

被引:0
|
作者
Rodriguez-Suarez, Eva [1 ]
Cardner, Mathias [2 ]
Wechsler, Michael E. [3 ]
Merkel, Peter A. [4 ]
Terrier, Benjamin [5 ,6 ]
Jayne, David R. W. [7 ]
Roufosse, Florence [8 ]
Agmon-Levin, Nancy [9 ]
Sjo, Lena Borjesson [10 ]
Necander, Sofia [10 ]
Jison, Maria [11 ]
Muthas, Daniel [2 ]
Mccrae, Christopher [12 ]
机构
[1] AstraZeneca, Translat Sci & Expt Med, Early Resp & Immunol, BioPharmaceut R&D, Cambridge, England
[2] AstraZeneca, Translat Sci & Expt Med, Early Resp & Immunol, BioPharmaceut R&D, Gothenburg, Sweden
[3] Natl Jewish Hlth, Dept Med, Denver, CO USA
[4] Univ Penn, Div Rheumatol, Philadelphia, PA USA
[5] Hosp Cochin, Natl Referral Ctr Rare Syst Autoimmune Dis, Dept Internal Med, Paris, France
[6] Univ Paris Cite, Paris, France
[7] Univ Cambridge, Dept Med, Cambridge, England
[8] Univ Libre Bruxelles, Hop Erasme, Dept Internal Med, Brussels, Belgium
[9] Sheba Med Ctr, Ramat Gan, Israel
[10] AstraZeneca, Late stage Resp & Immunol, BioPharmaceut R&D, Gothenburg, Sweden
[11] AstraZeneca, Late stage Resp & Immunol, BioPharmaceut R&D, Gaithersburg, MD USA
[12] AstraZeneca, Translat Sci & Expt Med, Early Resp & Immunol, BioPharmaceut R&D, Gaithersburg, MD USA
关键词
D O I
10.1183/13993003.congress-2024.PA828
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] The Effect of Benralizumab Versus Mepolizumab on the Depletion of Eosinophils in the Treatment of Eosinophilic Granulomatosis With Polyangiitis During the Phase 3 MANDARA Study
    Wechsler, M. E.
    Jackson, D. J.
    Specks, U.
    Pagnoux, C.
    Lugogo, N. L.
    Akuthota, P.
    Baudy, P.
    Sjo, L. Borjesson
    McCrae, C.
    Necander, S.
    Shavit, A.
    Walton, C.
    Rodriguez-Suarez, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [22] Low Dose of Mepolizumab in Treatment of Eosinophilic Granulomatosis with Polyangiitis
    Maia, A. P.
    San Martin, S. R.
    Erazo, A. C. E.
    Toledo, A. P.
    Oliveira, E. P.
    Assuncao, G. L.
    Barbas, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [23] Mepolizumab for the Treatment of Eosinophilic Granulomatosis With Polyangiitis: Our Experience
    Diaz-Campos, R. M.
    Prudencio-Ribera, V. C.
    Garcia-Moguel, I
    Fernandez-Rodriguez, C.
    Corral-Blanco, M.
    Jarrin-Estupinan, M. E.
    Melero-Moreno, C.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (05) : 384 - 385
  • [24] Benralizumab in cases of eosinophilic granulomatosis with polyangiitis
    Carrette, A.
    Mercier, V
    Lelubre, C.
    Peche, R.
    REVUE DES MALADIES RESPIRATOIRES, 2022, 39 (07) : 621 - 625
  • [25] Effect of Benralizumab vs Mepolizumab on Reduction in Oral Glucocorticoid (OGC) Use in Eosinophilic Granulomatosis with Polyangiitis (EGPA)
    Hellmich, B.
    Wechsler, M. E.
    Merkel, P. A.
    Nair, P.
    Bourdin, A.
    Jayne, D. R. W.
    Roufosse, F.
    Sjo, L. Borjesson
    Fan, Y.
    Menzies-Gow, A.
    Necander, S.
    Shavit, A.
    Rahmany, A.
    SWISS MEDICAL WEEKLY, 2024, 154 : 6S - 6S
  • [26] Complete Remission in Eosinophilic Granulomatosis with Polyangiitis (EGPA) in the MANDARA Trial of Benralizumab vs Mepolizumab
    Wechsler, M. E.
    Agmon-Levin, N.
    Jayne, D. R. W.
    Pagnoux, C.
    Specks, U.
    Sjo, L. Borjesson
    Necander, S.
    Shavit, A.
    Walton, C.
    Merkel, P. A.
    Worner, P.
    SWISS MEDICAL WEEKLY, 2024, 154 : 5S - 5S
  • [27] VASCULITIS Mepolizumab for eosinophilic granulomatosis with polyangiitis
    Guillevin, Loic
    NATURE REVIEWS RHEUMATOLOGY, 2017, 13 (09) : 518 - 519
  • [28] Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis
    Moiseev, Sergey
    Zagvozdkina, Eugenia
    Kazarina, Viktoria
    Bulanov, Nikolai
    Novikov, Pavel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (02) : 621 - 621
  • [29] Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
    Wechsler, M. E.
    Akuthota, P.
    Jayne, D.
    Khoury, P.
    Klion, A.
    Langford, C. A.
    Merkel, P. A.
    Moosig, F.
    Specks, U.
    Cid, M. C.
    Luqmani, R.
    Brown, J.
    Mallett, S.
    Philipson, R.
    Yancey, S. W.
    Steinfeld, J.
    Weller, P. F.
    Gleich, G. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (20): : 1921 - 1932
  • [30] Mepolizumab to treat eosinophilic granulomatosis with polyangiitis
    Rubio, Jose Luis Callejas
    Higueras, Manuela Moreno
    Centeno, Norberto Ortego
    MEDICINA CLINICA, 2024, 162 (03):